← Leaderboards
Thomas E Yankeelov
University Of Alabama At Birmingham
$17,847,366
Attributed
$29,297,725
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,297,725 · 16
By mechanism
R01$10,833,553 · 5
U01$8,814,970 · 3
U24$3,165,237 · 1
P30$2,304,433 · 2
R25$1,694,061 · 1
P50$1,382,645 · 2
Top collaborators
- Vito Quaranta12 shared
- Vandana Abramson10 shared
- Amy Brock9 shared
- Erin C Rericha6 shared
- Gregory S Karczmar5 shared
- Michael T Lewis5 shared
- Rita Nanda5 shared
- Daniel L Rubin5 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Kurt R Zinn$3,944,617
- Anna C Sorace$4,325,252
- Susan Elizabeth Birket$3,710,278
- David T Curiel$31,690,411
- Michael I Goran$47,330,547
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorResponseImageMagnetic Resonance ImagingTreatment ResponseClinical TrialsIn VivoMalignant NeoplasmsMolecularImaging ModalityPositron-Emission TomographyProtocols DocumentationAnimalsMonitorClinically RelevantMeasurementPre-ClinicalPhysiologicalScienceCommunitiesResourcesUniversitiesMalignant Breast NeoplasmCellularity
Grant awards (89)
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$1,877,237
R01 · FY2025 · CA
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer$466,308
R01 · FY2025 · CA
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer$442,688
R01 · FY2024 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$1
U01 · FY2024 · CA
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$1
R01 · FY2024 · CA
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$647,029
R01 · FY2023 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$620,231
U24 · FY2023 · CA
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer$477,800
R01 · FY2023 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$421,433
U01 · FY2023 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$79,365
U01 · FY2023 · CA
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy$684,353
R01 · FY2022 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$620,234
U24 · FY2022 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$421,433
U01 · FY2022 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$79,365
U01 · FY2022 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$632,898
U24 · FY2021 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$430,034
U01 · FY2021 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$80,986
U01 · FY2021 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$42,877
U01 · FY2021 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$632,900
U24 · FY2020 · CA
Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance$443,314
U01 · FY2020 · CA
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCER$658,974
U24 · FY2019 · CA
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$561,337
R01 · FY2019 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$426,704
U01 · FY2019 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$570,484
R01 · FY2018 · CA
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$464,348
U01 · FY2018 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$461,172
U01 · FY2018 · CA
Animal and Human Imaging Shared Resource$196,682
P30 · FY2018 · CA · contact PI
Animal and Human Imaging Shared Resource$10,000
P30 · FY2018 · CA · contact PI
Animal and Human Imaging Shared Resource$7,998
P30 · FY2018 · CA · contact PI
Animal and Human Imaging Shared Resource$7,970
P30 · FY2018 · CA · contact PI
Animal and Human Imaging Shared Resource$4,818
P30 · FY2018 · CA · contact PI
Animal and Human Imaging Shared Resource$4,735
P30 · FY2018 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$562,502
R01 · FY2017 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$461,999
U01 · FY2017 · CA
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$213,114
U01 · FY2017 · CA · contact PI
Animal and Human Imaging Shared Resource$196,682
P30 · FY2017 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$462,791
U01 · FY2016 · CA
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$211,784
U01 · FY2016 · CA · contact PI
Animal and Human Imaging Shared Resource$191,098
P30 · FY2016 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$152,843
R01 · FY2016 · CA
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$621,510
R01 · FY2015 · CA
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$541,380
U01 · FY2015 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$293,260
U01 · FY2015 · CA
Animal and Human Imaging Shared Resource$191,098
P30 · FY2015 · CA · contact PI
Animal and Human Imaging Shared Resource$110,381
P30 · FY2015 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$621,510
R01 · FY2014 · CA
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$557,192
U01 · FY2014 · CA · contact PI
Evaluation and Validation of Imaging Biomarkers of Tumor Response to Treatment$504,331
R01 · FY2014 · CA · contact PI
Multidisciplinary Training in Basic and Translational Imaging of Cancer$482,421
R25 · FY2014 · CA · contact PI
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$424,053
U01 · FY2014 · CA · contact PI
Animal and Human Imaging Shared Resource$320,357
P30 · FY2014 · CA · contact PI
Integrating Quantitative Imaging and Biophysical Models to Predict Tumor Growth$164,278
R21 · FY2014 · CA · contact PI
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$540,382
U01 · FY2013 · CA · contact PI
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$412,115
U01 · FY2013 · CA · contact PI
Multidisciplinary Training in Basic and Translational Imaging of Cancer$342,658
R25 · FY2013 · CA · contact PI
Animal and Human Imaging Shared Resource$313,048
P30 · FY2013 · CA · contact PI
Integrating Quantitative Imaging and Biophysical Models to Predict Tumor Growth$203,288
R21 · FY2013 · CA · contact PI
Evaluation and Validation of Imaging Biomarkers of Tumor Response to Treatment$121,030
R01 · FY2013 · CA · contact PI
Evaluation and Validation of Imaging Biomarkers of Tumor Response to Treatment$453,392
R01 · FY2012 · CA · contact PI
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$439,708
U01 · FY2012 · CA · contact PI
Multidisciplinary Training in Basic and Translational Imaging of Cancer$434,342
R25 · FY2012 · CA · contact PI
Animal and Human Imaging Shared Resource$241,045
P30 · FY2012 · CA · contact PI
Imaging Core$157,184
P50 · FY2012 · CA · contact PI
Small Animal Imaging Core$104,754
P50 · FY2012 · CA · contact PI
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$48,822
U01 · FY2012 · CA · contact PI
Evaluation and Validation of Imaging Biomarkers of Tumor Response to Treatment$453,325
R01 · FY2011 · CA · contact PI
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$440,658
U01 · FY2011 · CA · contact PI
Multidisciplinary Training in Basic and Translational Imaging of Cancer$434,640
R25 · FY2011 · CA · contact PI
Evaluation of MRI Biomarkers of Breast Cancer Response$307,024
R01 · FY2011 · CA · contact PI
Animal and Human Imaging Shared Resource$243,760
P30 · FY2011 · CA · contact PI
Imaging Core$148,670
P50 · FY2011 · CA · contact PI
Small Animal Imaging Core$120,691
P50 · FY2011 · CA · contact PI
PET-MRI for Assessing Treatment Response in Breast Cancer Clinical Trials$416,680
U01 · FY2010 · CA · contact PI
Evaluation and Validation of Imaging Biomarkers of Tumor Response to Treatment$373,101
R01 · FY2010 · CA · contact PI
Evaluation of MRI Biomarkers of Breast Cancer Response$316,562
R01 · FY2010 · CA · contact PI
Animal and Human Imaging Shared Resource$264,761
P30 · FY2010 · CA · contact PI
Small Animal Imaging Core$163,648
P50 · FY2010 · CA · contact PI
Imaging Core$148,353
P50 · FY2010 · CA · contact PI
Evaluation of MRI Biomarkers of Breast Cancer Response$316,603
R01 · FY2009 · CA · contact PI
Small Animal Imaging Core$165,711
P50 · FY2009 · CA · contact PI
Imaging Core$155,099
P50 · FY2009 · CA · contact PI
MRI Evaluation of Tumor Growth and Treatment Response$153,339
K25 · FY2009 · EB · contact PI
Evaluation of MRI Biomarkers of Breast Cancer Response$302,583
R01 · FY2008 · CA · contact PI
MRI Evaluation of Tumor Growth and Treatment Response$150,104
K25 · FY2008 · EB · contact PI
Small Animal Imaging Core$119,578
P50 · FY2008 · CA · contact PI
Imaging Core$98,957
P50 · FY2008 · CA · contact PI
MRI Evaluation of Tumor Growth and Treatment Response$146,960
K25 · FY2007 · EB · contact PI
MRI Evaluation of Tumor Growth and Treatment Response$143,910
K25 · FY2006 · EB · contact PI
MRI Evaluation of Tumor Growth and Treatment Response$140,947
K25 · FY2005 · EB